Clinical management of breast pain: A review

Obstetrical and Gynecological Survey

Volumn 57, Issue 7, 2002, Pages 451-461

  Millet, Antonio V ^a   Dirbas, Frederick M ^a  

^a Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DANAZOL; GESTRINONE; GONADORELIN AGONIST; PRIMROSE OIL; TAMOXIFEN;

ANAMNESIS; ANXIETY; BEHAVIOR; BREAST CANCER; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLOTHING; CONSULTATION; DAILY LIFE ACTIVITY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; MASTALGIA; PAIN ASSESSMENT; PATHOGENESIS; PHYSICAL EXAMINATION; PHYSICIAN ATTITUDE; PREMENSTRUAL SYNDROME; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW;

BREAST; CLOTHING; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MENSTRUAL CYCLE; PAIN;

EID: 0036318251     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200207000-00022     Document Type: Review

References (93)

1. Managing breast pain
2. Etiology and management of breast pain
3. Consultations for breast disease in general practice and hospital referral patterns
4. Mastalgia
5. Management of cyclical breast pain
6. Drug treatment of mastalgia: What are the opinions?
7. Mastalgia. A 3-year Australian study
8. Cyclical mastalgia: Prevalence and impact in an outpatient breast clinic sample
9. Cyclycal mastalgia: Prevalence and associated health and behavioral factors
10. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample
11. Non-cyclical mastalgia. An improved classification and treatment
12. Maintenance therapy of cyclical mastalgia using low-dose danazol
13. The long-term course of mastalgia
14. Sports brassiere: Is it a solution for mastalgia?
15. Breast pain and nodularity
16. Chronic pain in primary care: Identification and management of psychosocial factors
17. Relationship of cyclical mastalgia to PMS
18. Cyclical mastalgia: Premenstrual syndrome or recurrent pain disorder?
19. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms
20. Gender variations in clinical pain experience
21. Methylxanthine and fibrocystic breast disease: A study of correlations
22. Nonendocrine theories of etiology of benign breast disease
23. The effect of decreased caffeine consumption on benign proliferative disease
24. Management of breast pain
25. Methylxantines in benign breast disease
26. Cyclical mastalgia as a marker of breast cancer susceptibility: Results of a case-control study among French women
27. Value of breast imaging in women with painful breasts: Observational follow-up study
28. Breast pain
29. Mastalgia: Is this commonly associated with operable breast cancer?
30. Localized mastalgia as presenting symptom in breast cancer
31. Mastodynia
32. Inflammatory changes to ducts in mammary dysplasia: A cause of duct obliteration
33. Cyclical mastalgia and breast pathology
34. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: Update on the European Trial
35. Plasma fatty acid profiles in benign breast disorders
36. Inadequate corpus luteum function in women with benign breast diseases
37. Urinary and plasma androgens in benign breast disease
38. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia
39. Psychiatric illness in patients with severe treatment-resistant mastalgia
40. Psychiatric illness in patients with severe treatment-resistant mastalgia
41. Experimental and clinical evidences for a role of prolactin in human breast cancer and the possible usefulnesss in combining hyperprolactinemic drugs with standard hormonal treatments
42. Hormonal profile in benign breast disease: Endocrine status of cyclical mastalgia patients
43. Hormonal profile in benign breast disease: Endocrine status of cyclical mastalgia patients
44. Premenstrual syndrome and premenopausal breast pain (cyclical mastalgia): Disorders of essential fatty acid (EFA) metabolism
45. Clinical evaluation of mastalgia
46. Drug treatments for mastalgia: 17 Years experience in the Cardiff mastalgia clinic
47. Mastalgia
48. Assessment of breast problems
49. Clinical experience of drug treatment for mastalgia
50. Mastalgia
51. Clinical approach to breast disease
52. Breast health and associated premenstrual symptoms in women with severe cyclic mastalgia
53. Women with severe problems must be seen in specialist breast clinics
54. Value of breast imaging in women with painful breasts
55. Reassurance in the treatment of mastalgia
56. Importance of mastalgia in operable breast cancer
57. Cyclic breast pain: Some observations and the difficulties in treatment
58. Spectrum of benign breast disorders in a university hospital
59. Caffeine restriction as initial treatment of breast pain
60. Fibrocystic change and fibrocystic disease of the breast
61. Treatment with benign breast disease with vitamin A
62. Vitamin E and benign breast disease: A double-blind, randomized clinical trial
63. Vit B6 in the treatment of premenstrual mastalgia
64. Effect of a low fat high-carbohydrate diet on symptoms of cyclical mastopathy
65. Cyclical mastalgia: Is it a manifestation of aberration in lipid metabolism?
66. Mastalgia refractory to drug treatment
67. Natural history of breast pain
68. Treatment of cyclical mastalgia with low-dose short-term danazol
69. Mastalgia: Tailoring treatment to type of breast pain
70. Double-blind controlled trial of tamoxifen therapy for mastalgia
71. Treatment of premenstrual mastalgia with tamoxifen
72. Dosage and duration of tamoxifen treatment for mastalgia: A controlled trial
73. Tamoxifen therapy for cyclical mastalgia: A controlled trial
74. Tamoxifen and benign breast problems
75. Comparison of tamoxifen with Danazol for treatment of cyclical mastalgia
76. Comparison of tamoxifen and Bromocriptine in managemetn of fibrocystic breast disease: A randomized blind study
77. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers
78. Tamoxifen and mastalgia: An emerging indication
79. European Multicenter Trial of bromocriptine in cyclical mastalgia
80. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia
81. Mastodynia
82. Bromocriptine indications withdrawn
83. Fibrocystic disease of the breast in premenopausal women: Histohormonal correlation and response to Luteinizing Hormone Releasing Hormone Analogue treatment
84. Management of severe fibrocystic disease of the breast with leuprolide acetate
85. Multicenter study of gestrinone in cyclical breast pain
86. Nimesulide in the treatment of mastalgia
87. Breast pain and nodularity
88. Psychological distress associated to with severe mastalgia
89. Mood changes - An explanation why women request treatment for cyclical mastalgia
90. Are patients with mastalgia anxious, and does relaxation therapy help?
91. Non-cyclical mastalgia: An improved classification and treatment
92. Management of the painful and nodular breast